Results 261 to 270 of about 1,877,160 (342)
New Strategies in Comprehensive Melanoma Treatment: Applications, Potential, and Challenges of Hydrogels. [PDF]
Jin Q +7 more
europepmc +1 more source
Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives. [PDF]
Makkar SK.
europepmc +1 more source
Covalent Activation of the C‐type Lectin DC‐SIGN
We introduce the first covalent activators of a C‐type lectin. Using orthogonal functional assays, NMR, MS/MS, and computational modeling, we delineate mechanisms from a functional electrophile‐first screen on dendritic cell‐specific intercellular adhesion molecule‐3‐grabbing non‐integrin (DC‐SIGN) that yields two modes: N‐hydroxysuccinimide (NHS ...
Jonathan Lefèbre +9 more
wiley +1 more source
Emerging technologies transforming the future of global biosecurity. [PDF]
de Lima RC, Quaresma JAS.
europepmc +1 more source
Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy. [PDF]
Anilkumar AS +2 more
europepmc +1 more source
Somatic Embryogenesis: A Biotechnological Route in the Production of Recombinant Proteins. [PDF]
Ramírez-Mosqueda MA +6 more
europepmc +1 more source
A Multiepitope‐Based Lateral Flow Assay for Leprosy Antibodies
An innovative lateral flow assay for leprosy diagnosis is based on gold nanoparticles and synthetic Mycobacterium leprae epitopes conjugated to keyhole limpet hemocyanin protein to enhance antibody detection. This strategy provides a rapid, accurate, and low‐cost approach for resource‐limited settings, enabling the early detection of infection. Leprosy
Cristiane Zocatelli‐Ribeiro +7 more
wiley +1 more source
Reprogramming cancer immunity with next-generation combination therapies. [PDF]
Kyriakidis NC +9 more
europepmc +1 more source
ABSTRACT Lipid‐based nanoparticles (LNPs) are favored for drug delivery because of their low toxicity, high biocompatibility, ability to self‐assemble into nanoparticles, and ability to enhance drug bioavailability, thereby improving drug release modulation and pharmacokinetics.
Gulizar Caliskan +3 more
wiley +1 more source

